This part of the site is strictly dedicated to healthcare professionals practicing in malarial endemic areas

MALARIA NEWS

Information and Training


Submit Advanced search
     


General | Diagnostic tools | Diagnostic strategy | The blood smear test | Thick blood film technique | The QBC-malaria test ® | Detection of the HRP2 antigen | Staining techniques | Identification of parasites

[08/25/2004]
 Diagnostic strategy

 The normal microscopic diagnostic techniques are the thick blood films and especially the thin film blood smear test. The reliability of these examinations is conditioned by their successful technical performance.  

The routine use in medical analysis laboratories of the majority of the new parasitological diagnostic techniques may not be envisaged for a number of years yet. Only the QBC-Malaria Test® and the HRP2 based tests, specifically for Plasmodium falciparum, currently present any practical interest. 




| > Diagnostic strategy in laboratories equipped with a microscope and QBC-Malaria Test® equipment | > Diagnostic strategy in laboratories equipped with a microscope | > Diagnosis in the field

The QBC-Malaria Test® remains the most sensitive parasitologic test: it should retain its place in the front line. HRP2 detection should be associated with it in the event of positive reaction, systematically for a poorly trained biologist, and when parasitemia is low. 

When the QBC-Malaria Test® is negative, HRP2 detection is only of interest if a search finds signs of recent antimalarial treatment: evidence of HRP2, in this case, provides proof of the plasmodium at the origin of the disease.

In a susceptible population, if the QBC-Malaria Test® is not available, the thin blood film smear– HRP2 test combination is necessary.

HRP2 based tests are adapted for use in a precarious or isolated situations. In this case, it should be considered as a standby test in the absence of medical and/or biological assistance.

The presence of rare false positives and the existence of other plasmodium species prohibit, while awaiting multi-species tests, the isolated and exclusive use of HRP2 based tests for the biological diagnosis of malaria. 

 Diagnostic strategy in laboratories equipped with a microscope and QBC-Malaria Test® equipment

Respective interest of the 3 tests:

QBC Malaria Test®

  • parasitological diagnosis of the Plasmodium of human interest 
  • parasitological diagnosis of other sanguicolous parasites (trypanosomes, filariae, etc.)  

Search for the HRP2 antigen:

  • identification argument for Plasmodium falciparum when a Plasmodium is shown to exist by the QBC Malaria Test® 
  • elimination of false positives linked to the reading of the QBC Malaria Test® by staff not familiar with parasitological diagnosis 
  • argument for incriminating Plasmodium falciparum when a patient is seen "a second time around" after self-treatment or a presumptive treatment which lowered the parasitic density below the detection threshold of the parasitological tests. 
  • Possibility of remote supervision in time and space  

Smear test 

  • evaluation of the parasitic density of Plasmodium falciparum 
  • parasitological diagnosis of the Plasmodium of human interest and other sanguicolous parasites 
  • indirect hematological signs of malaria infection (hematological syndrome associating relative thrombopenia and the presence of activated lymphocytes)  
  • possibility of remote supervision in time and space 
 Diagnostic strategy in laboratories equipped with a microscope

Respective interest of the two tests:

Smear test

  • evaluation of parasitic density of Plasmodium falciparum 
  • parasitological diagnosis of the Plasmodium of human interest and other sanguicolous parasites 
  • indirect hematologiqal signs of malarial infection (hematological syndrome associating relative thrombopenia and the presence of activated lymphocytes) 
  • possibility of remote supervision in time and space  

Search for the HRP2 antigen:

  • confirms the identification of Plasmodium falciparum, in particular when the parasitic density is too low for a parasitological identification on a thin blood film smear 
  • argument to incriminate Plasmodium falciparum when a patient is seen "a second time around" after a self-treatment or a presumptive treatment which lowered the parasitic density below the detection threshold of the parasitological tests 
  • possibility of remote supervision in time and space  
 Diagnosis in the field

Interest of the test:

 Positive test 

  • major argument to confirm the presence of trophozoites of Plasmodium falciparum, without being able to differentiate between a malaria infection and a malaria disease which, in these circumstances, has no repercussions on the conduct to be taken. 
  • argument for the adaptation of the presumptive treatment of malaria in relation to the local level of resistance of Plasmodium falciparum to antimalarial drugs. 
  • argument for judging the urgency of sanitary evacuation 
  • possibility of remote supervision in time and space  

 Negative test 

  • strong argument against malaria disease or malaria infection by Plasmodium falciparum.  

This strategy should be integrated into a strategy of standby treatment and imposes a medical consultation as soon as possible. It does not dispense the performance of a blood smear test which would be read later. A negative test does not dispense the patient undergoing systematic treatment. 

 

© Copyright sanofi-aventis 2002-2008 all rights reserved
Disease information about malaria:the parasite, the symptoms, prevention and treatment options, atlas of malaria, etc.